Heron Therapeutics (HRTX) vs Oncolytics Biotech (ONCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Oncolytics Biotech (ONCY) has outperformed Heron Therapeutics (HRTX) over the past year, losing 55.9% versus a loss of 70.9%. Over five years, ONCY leads with a -73.2% price change compared with -96.4% for HRTX. Oncolytics Biotech is the larger company by market cap ($71.4 million vs $68.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HRTX | ONCY |
|---|---|---|
| Share price | $0.3582 | $0.5444 |
| Market cap | $68.01M | $71.38M |
| 1-day change | -6.79% | -8.63% |
| YTD return | -70.44% | -31.52% |
| 1-year return | -70.89% | -55.87% |
| 5-year return | -96.37% | -73.16% |
| EPS (TTM) | $-0.18 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.58 | $1.32 |
| 52-week low | $0.26 | $0.5418 |
| Distance from 52-week high | -77.33% | -58.76% |
| Average volume | 2.58M | 1.10M |
| Shares outstanding | 189.85M | 131.12M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ONCY has outperformed HRTX by 15.0 percentage points over the past year.
HRTX vs ONCY FAQ
Which is bigger, Heron Therapeutics or Oncolytics Biotech?
Oncolytics Biotech (ONCY) is larger, with a market capitalization of $71.38M compared with $68.01M for Heron Therapeutics (HRTX).
Which stock has performed better over the past year, HRTX or ONCY?
ONCY returned -55.87% over the past 12 months, compared with -70.89% for HRTX (price return, excluding dividends). Past performance does not predict future results.
Are Heron Therapeutics and Oncolytics Biotech in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.